Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer

被引:13
|
作者
Valicenti, RK
Chervoneva, I
Gomella, LG
机构
[1] Thomas Jefferson Univ Hosp, Bodine Ctr Canc Treatment, Kimmel Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA
[4] Thomas Jefferson Univ Hosp, Jefferson Med Coll, Dept Urol, Philadelphia, PA 19107 USA
关键词
prostate cancer; Gleason score; surgical margins; radiotherapy;
D O I
10.1016/j.ijrobp.2003.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate, in Gleason score 7, pT3N0 prostate cancer patients with positive surgical margins, the predictors of progression-free survival and to identify a patient subgroup that would benefit from immediate adjuvant postoperative radiotherapy (ART). Methods and Materials: Between November 1989 and August 1998, 76 men underwent radical prostatectomy and were found to have capsular penetration (pT3N0), surgical Gleason score 7, tumor present at the resection margin, and an undetectable postoperative prostate-specific antigen (PSA) level. All surgical specimens underwent whole-mount serial sectioning to determine the degree of margin positivity (focal vs. extensive). Of the 76 men, 45 underwent early ART (within 6 months with a median dose of 64.8 Gy), and 31 had no immediate treatment. We defined freedom from PSA failure (bNED) as the absence of two consecutive PSA rises >0.2 ng/mL. Results: The median follow-up time was 5.1 years (range, 2-10 years). The ART and non-ART patients were similar with respect to preoperative PSA level, Gleason score (4 + 3 vs. 3 + 4), presence of seminal vesicle invasion, and margin extent. On univariate analysis, margin extent was predictive for improved bNED (5-year bNED rate of 92% vs. 58%, p = 0.010, for men with focal and extensive margins, respectively). Gleason score (4 + 3 vs. 3 + 4), seminal vesicle invasion, and ART were not statistically significant predictors. On multivariate analysis, the preoperative PSA level, margin extent, and ART were independent significant factors. In the group with extensive surgical margins, men receiving ART had a significantly greater 5-year bNED survival rate compared with the non-ART patients (73% vs. 31%, p = 0.004). Conclusion: These data suggest that the amount of microscopic residual tumor significantly affects bNED after radical prostatectomy for Gleason score 7, pT3N0 prostate cancer. In addition, men with pathologic evidence of microscopic local disease appear to benefit from early ART compared with untreated controls. (C) 2004 Elsevier Inc.
引用
收藏
页码:1093 / 1097
页数:5
相关论文
共 50 条
  • [21] Who needs postoperative CCRT in patients with pT3N0 rectal cancer with negative resection margin?
    Baek, J. Y.
    Il, Y. Jeong
    Chul, P. Hee
    Ho, C. Doo
    Sang, Y. Gyu
    Kyung, C. Won
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S580 - S580
  • [22] Extramural Extension as Indicator for Postoperative Adjuvant Chemotherapy in Stage IIA (pT3N0) Colon Cancer
    Akagi, Yoshito
    Shirouzu, Kazuo
    Kinugasa, Tetsushi
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (06) : 358 - 363
  • [23] Patterns and Predictors of Early Biochemical Recurrence After Radical Prostatectomy and Adjuvant Radiation Therapy in Men With pT3N0 Prostate Cancer: Implications for Multimodal Therapies
    Briganti, Alberto
    Joniau, Steven
    Gandaglia, Giorgio
    Cozzarini, Cesare
    Sun, Maxine
    Tombal, Bertrand
    Haustermans, Karin
    Hinkelbein, Wolfgang
    Shariat, Shahrokh F.
    Karakiewicz, Pierre I.
    Montorsi, Francesco
    Van Poppel, Hein
    Wiegel, Thomas
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (05): : 960 - 967
  • [24] Prostate specific antigen outcome based on the extent of extracapsular extension and margin status in patients with seminal vesicle negative prostate carcinoma of Gleason score ≤ 7
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Tomaszewski, JE
    Wein, A
    CANCER, 2000, 88 (09) : 2110 - 2115
  • [25] pT3N0M0 prostate cancer: a plea for adjuvant radiation
    Michel Bolla
    Laurence Collette
    Nature Reviews Urology, 2009, 6 : 410 - 412
  • [26] Adjuvant radiotherapy or early salvage radiotherapy in pT3R0 or pT3R1 prostate cancer
    Bartkowiak, Detlef
    Bottke, Dirk
    Wiegel, Thomas
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 360 - 365
  • [27] Occult pelvic lymph node (PLN) metastases in patients with "pT3N0" prostate cancer (PCa)
    Wilcox, GE
    Kattan, MW
    Slawin, KM
    Scardino, PT
    Wheeler, TM
    MODERN PATHOLOGY, 1998, 11 (01) : 99A - 99A
  • [28] Poor prognostic subgroup in pT3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy
    Imamura, Taisuke
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Kubota, Takeshi
    Okamoto, Kazuma
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Otsuji, Eigo
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (04) : E94 - E95
  • [29] Risk of biochemical recurrence and timing of radiotherapy in pT3a N0 prostate cancer with positive surgical margin
    Hegemann, Nina-Sophie
    Morcinek, Sebastian
    Buchner, Alexander
    Karl, Alexander
    Stief, Christian
    Knuechel, Ruth
    Corradini, Stefanie
    Li, Minglun
    Belka, Claus
    Ganswindt, Ute
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (07) : 440 - 448
  • [30] Effect of Postoperative Radiotherapy on Survival for Surgically Managed pT3N0 and pT4aN0 Laryngeal Cancer: Analysis of the National Cancer Data Base
    Graboyes, Evan M.
    Zhan, Kevin Y.
    Garrett-Mayer, Elizabeth
    Lentsch, Eric J.
    Sharma, Anand K.
    Day, Terry A.
    CANCER, 2017, 123 (12) : 2248 - 2257